PMID- 35628567 OWN - NLM STAT- MEDLINE DCOM- 20220531 LR - 20220716 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 23 IP - 10 DP - 2022 May 20 TI - Inhibitory Effects of Saururus chinensis Extract on Receptor for Advanced Glycation End-Products-Dependent Inflammation and Diabetes-Induced Dysregulation of Vasodilation. LID - 10.3390/ijms23105757 [doi] LID - 5757 AB - Advanced glycation end-products (AGEs) and the receptor for AGEs (RAGE) are implicated in inflammatory reactions and vascular complications in diabetes. Signaling pathways downstream of RAGE are involved in NF-kappaB activation. In this study, we examined whether ethanol extracts of Saururus chinensis (Lour.) Baill. (SE) could affect RAGE signaling and vascular relaxation in streptozotocin (STZ)-induced diabetic rats. Treatment with SE inhibited AGEs-modified bovine serum albumin (AGEs-BSA)-elicited activation of NF-kappaB and could compete with AGEs-BSA binding to RAGE in a dose-dependent manner. Tumor necrosis factor-alpha (TNF-alpha) secretion induced by lipopolysaccharide (LPS)-a RAGE ligand-was also reduced by SE treatment in wild-type Ager(+/+) mice as well as in cultured peritoneal macrophages from Ager(+/+) mice but not in Ager(-/-) mice. SE administration significantly ameliorated diabetes-related dysregulation of acetylcholine-mediated vascular relaxation in STZ-induced diabetic rats. These results suggest that SE would inhibit RAGE signaling and would be useful for the improvement of vascular endothelial dysfunction in diabetes. FAU - Hayashi, Kenjiro AU - Hayashi K AD - Food Development Labs, Functional Food Division, Nippon Shinyaku Co., Ltd., Kyoto 601-8550, Japan. AD - Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan. FAU - Sato, Koichi AU - Sato K AD - Food Development Labs, Functional Food Division, Nippon Shinyaku Co., Ltd., Kyoto 601-8550, Japan. FAU - Ochi, Seishi AU - Ochi S AD - Food Development Labs, Functional Food Division, Nippon Shinyaku Co., Ltd., Kyoto 601-8550, Japan. FAU - Kawano, Shuhei AU - Kawano S AD - Food Development Labs, Functional Food Division, Nippon Shinyaku Co., Ltd., Kyoto 601-8550, Japan. FAU - Munesue, Seiichi AU - Munesue S AD - Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan. FAU - Harashima, Ai AU - Harashima A AD - Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan. FAU - Oshima, Yu AU - Oshima Y AD - Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan. FAU - Kimura, Kumi AU - Kimura K AD - Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan. FAU - Kyoi, Takashi AU - Kyoi T AD - Food Development Labs, Functional Food Division, Nippon Shinyaku Co., Ltd., Kyoto 601-8550, Japan. FAU - Yamamoto, Yasuhiko AU - Yamamoto Y AUID- ORCID: 0000-0003-1326-4649 AD - Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan. LA - eng PT - Journal Article DEP - 20220520 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Carrier Proteins) RN - 0 (NF-kappa B) RN - 0 (Plant Extracts) RN - 0 (Receptor for Advanced Glycation End Products) RN - 0 (Receptors, Immunologic) SB - IM MH - Animals MH - Carrier Proteins MH - *Diabetes Mellitus, Experimental/drug therapy/metabolism MH - Inflammation/drug therapy MH - Mice MH - NF-kappa B/metabolism MH - Plant Extracts/pharmacology MH - Rats MH - Receptor for Advanced Glycation End Products/genetics/metabolism MH - Receptors, Immunologic/genetics/metabolism MH - *Saururaceae/metabolism MH - Vasodilation PMC - PMC9147798 OTO - NOTNLM OT - Saururus chinensis (Lour.) Baill OT - receptor for advanced glycation end-products (RAGE) OT - vascular relaxation COIS- The authors declare no conflict of interest. EDAT- 2022/05/29 06:00 MHDA- 2022/06/01 06:00 PMCR- 2022/05/20 CRDT- 2022/05/28 01:23 PHST- 2021/12/17 00:00 [received] PHST- 2022/05/19 00:00 [revised] PHST- 2022/05/19 00:00 [accepted] PHST- 2022/05/28 01:23 [entrez] PHST- 2022/05/29 06:00 [pubmed] PHST- 2022/06/01 06:00 [medline] PHST- 2022/05/20 00:00 [pmc-release] AID - ijms23105757 [pii] AID - ijms-23-05757 [pii] AID - 10.3390/ijms23105757 [doi] PST - epublish SO - Int J Mol Sci. 2022 May 20;23(10):5757. doi: 10.3390/ijms23105757.